You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Claims for Patent: 9,522,249


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,522,249
Title:Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
Inventor(s): Rounbehler; David P. (Lexington, MA), Fine; David H. (Cocoa Beach, FL)
Assignee: GENO LLC (Cocoa, FL)
Application Number:14/107,629
Patent Claims: 1. An apparatus for converting nitrogen dioxide to nitric oxide suitable for delivery to a human comprising a receptacle including an inlet a cartridge comprising a permeable support comprising vitamin C or Vitamin E, and an outlet, and wherein the inlet is configured to receive a gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the outlet, such that the gas flow contacts the vitamin inside the receptacle, and the vitamin converts substantially all of the nitrogen dioxide in the gas flow to nitric oxide.

2. The apparatus of claim 1, wherein the permeable support comprises a substrate that retains water.

3. The apparatus of claim 1, wherein the permeable support comprises a silica gel.

4. The apparatus of claim 1, wherein the vitamin includes ascorbic acid, alpha tocopherol or gamma tocopherol.

5. An apparatus for generating a therapeutic gas including nitric oxide comprising: a permeation cell having liquid nitrogen dioxide and capable of diffusing gaseous nitrogen dioxide into a gas flow; and a receptacle including an inlet, an outlet and disposed within said receptacle a vitamin C or vitamin E, wherein the inlet is configured to receive the gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the outlet, such that the gas flow contacts the vitamin inside the receptacle, and the vitamin converts substantially all of the nitrogen dioxide in the gas flow to nitric oxide, thereby generating a therapeutic gas including nitric oxide.

6. The apparatus of claim 5, wherein the receptacle is a first receptacle, the apparatus further comprising a second receptacle including a second inlet, a second outlet and a second vitamin, wherein the second inlet is configured to receive the gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the second outlet, such that the gas flow contacts the second vitamin inside the second receptacle, and the second vitamin converts substantially all of the nitrogen dioxide in the gas flow to nitric oxide.

7. The apparatus of claim 6, wherein the vitamin in the first receptacle and the second vitamin are the same.

8. The apparatus of claim 5, wherein the receptacle further comprises a permeable support for the vitamin.

9. The apparatus of claim 8, wherein the permeable support for the vitamin comprises a substrate that retains water.

10. The apparatus of claim 9, wherein the permeable support for the vitamin comprises a silica gel.

11. The apparatus of claim 6, wherein the second receptacle further comprises a permeable support for the second vitamin.

12. The apparatus of claim 11, wherein the permeable support for the vitamin in the first receptacle and the permeable support for the second vitamin are the same.

13. The apparatus of claim 5, further comprising an air pump capable of generating the gas flow, wherein the permeation cell is configured to receive the gas flow generated by the air pump.

14. The apparatus of claim 13, wherein the air pump is portable.

15. The apparatus of claim 5, further comprising an oxygen-enrichment device capable of supplying oxygen in the gas flow, wherein the permeation cell is configured to receive the gas flow enriched by the oxygen-enrichment device.

16. The apparatus of claim 5, wherein the vitamin comprises ascorbic acid, alpha tocopherol or gamma tocopherol.

17. The apparatus of claim 6, further comprising a flexible bag operable to inflate and deflate as a mammal receiving the therapeutic gas breathes, and wherein the second receptacle is positioned between the flexible bag and a point at which the therapeutic gas flow including nitric oxide is delivered to the mammal.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.